277 related articles for article (PubMed ID: 18756360)
21. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
[TBL] [Abstract][Full Text] [Related]
22. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes.
Ford EC; Kinahan PE; Hanlon L; Alessio A; Rajendran J; Schwartz DL; Phillips M
Med Phys; 2006 Nov; 33(11):4280-8. PubMed ID: 17153406
[TBL] [Abstract][Full Text] [Related]
23. Multisphere phantom and analysis algorithm for PET image quality assessment.
Wilson JM; Turkington TG
Phys Med Biol; 2008 Jun; 53(12):3267-78. PubMed ID: 18506071
[TBL] [Abstract][Full Text] [Related]
24. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
[TBL] [Abstract][Full Text] [Related]
25. Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography.
Pönisch F; Richter C; Just U; Enghardt W
Phys Med Biol; 2008 Jul; 53(13):N259-68. PubMed ID: 18562779
[TBL] [Abstract][Full Text] [Related]
26. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
[TBL] [Abstract][Full Text] [Related]
27. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes.
Mawlawi O; Podoloff DA; Kohlmyer S; Williams JJ; Stearns CW; Culp RF; Macapinlac H;
J Nucl Med; 2004 Oct; 45(10):1734-42. PubMed ID: 15471842
[TBL] [Abstract][Full Text] [Related]
28. Fever of unknown origin: the role of 18F-FDG PET/CT.
Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
[TBL] [Abstract][Full Text] [Related]
29. Quantitative assessment of the influence of location, internal temperature, idle time, and normalization on the sensitivity of a mobile PET/CT scanner.
Belakhlef S; Church C; Hays A; Fraser R; Lakhanpal S
J Nucl Med Technol; 2008 Sep; 36(3):147-50. PubMed ID: 18703620
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography/computed tomography: the current technology and applications.
Mittra E; Quon A
Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
[TBL] [Abstract][Full Text] [Related]
31. A motion-incorporated reconstruction method for gated PET studies.
Qiao F; Pan T; Clark JW; Mawlawi OR
Phys Med Biol; 2006 Aug; 51(15):3769-83. PubMed ID: 16861780
[TBL] [Abstract][Full Text] [Related]
32. Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer.
Everitt C; Leong T
Australas Radiol; 2006 Jun; 50(3):271-4. PubMed ID: 16732830
[TBL] [Abstract][Full Text] [Related]
33. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
34. PET/CT for therapy response assessment in lymphoma.
Hutchings M; Barrington SF
J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
[TBL] [Abstract][Full Text] [Related]
35. Annihilation photon acollinearity in PET: volunteer and phantom FDG studies.
Shibuya K; Yoshida E; Nishikido F; Suzuki T; Tsuda T; Inadama N; Yamaya T; Murayama H
Phys Med Biol; 2007 Sep; 52(17):5249-61. PubMed ID: 17762084
[TBL] [Abstract][Full Text] [Related]
36. NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes.
Kemp BJ; Kim C; Williams JJ; Ganin A; Lowe VJ;
J Nucl Med; 2006 Dec; 47(12):1960-7. PubMed ID: 17138738
[TBL] [Abstract][Full Text] [Related]
37. High-density materials do not always induce artifacts on PET/CT: what is responsible for the difference?
Kaneta T; Takanami K; Wakayama Y; Sato A; Higano S; Fukuda H; Yamada S; Takahashi S
Nucl Med Commun; 2007 Jun; 28(6):495-9. PubMed ID: 17460541
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
39. SUV correction for injection errors in FDG-PET examination.
Miyashita K; Takahashi N; Oka T; Asakawa S; Lee J; Shizukuishi K; Inoue T
Ann Nucl Med; 2007 Dec; 21(10):607-13. PubMed ID: 18092139
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.
Tateishi U; Hosono A; Makimoto A; Nakamoto Y; Kaneta T; Fukuda H; Murakami K; Terauchi T; Suga T; Inoue T; Kim EE
Ann Nucl Med; 2009 Feb; 23(2):155-61. PubMed ID: 19225939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
